All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know ALL.
Educational theme│ Epidemiology and treatment landscape of Ph-positive ALL
A review of the epidemiology and treatment landscape of Ph+ ALL from several recently published articles.
Visual abstract | Phase II study of blinatumomab in patients with B-ALL and positive MRD at a minimum threshold of ≥10−4
The ALL Hub is pleased to present a visual abstract of a phase II trial (NCT02458014) of blinatumomab in adult patients with...
Your opinion matters
Are you a healthcare professional? What is your specialty?
Please select or type your specialty
By sharing this information, you can help ensure we continue to develop content that is of most relevance for our audience.
Thank you for submitting.